Mumbai, India – May 15, 2025 – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and a wholly owned subsidiary of PI Industries, today announced a strategic collaboration with Cresset to implement Torx® Software, a state-of-the-art cloud-based platform for small molecule drug discovery. This partnership marks a significant step in PI Health Sciences’ commitment to driving innovation, operational excellence, and transformative solutions across the pharmaceutical value chain.
Torx® Software, developed jointly by Cresset and Elixir Software, is the industry’s only comprehensive DMTA (design-make-test-analyze) platform. It empowers research teams to seamlessly coordinate molecule design, synthesis, testing, and data analysis in a single, integrated digital environment. By centralizing critical information and enabling real-time collaboration, Torx® streamlines decision-making, reduces cycle times, and enhances productivity in drug discovery projects.
Torx® in Action: Empowering PIHS Teams and Client Collaboration
- Client-Centric Collaboration: PIHS leverages Torx® to bring medicinal chemists, computational chemists, biologists, and project managers onto a unified platform, enabling seamless communication and collaborative design with our clients.
- Streamlined Project Execution: By integrating synthesis, testing, and analysis workflows, Torx® supports PIHS efficiently track compound progress—from ideation to delivery—ensuring transparency and timely updates for client programs.
- Actionable Design Insights: With advanced molecular visualization and property analytics, PIHS teams can make informed design decisions and iterate quickly in response to experimental results.
- Confidential & Compliant Data Handling: We ensures secure, IP-sensitive data sharing through Torx®, allowing trusted collaboration with internal stakeholders and client partners
- Efficient Data Integration: Torx® compatibility with platforms like CDD Vault supports PIHS in maintaining a smooth and organized data ecosystem for all ongoing discovery projects.
PI Health Sciences: Delivering Innovation with Human Ingenuity
PI Health Sciences has global presence across the USA, Europe, and Asia. PI Health Sciences offers end-to-end integrated drug discovery CRO, CDMO, KSM, and API solutions. Our team comprises globally experienced and Indian-seasoned drug discovery experts who have successfully contributed to multiple clinical candidates. Together, we are purposefully aligned to drive success across discovery programs. By integrating Torx® Software into its operations, PI Health Sciences will further strengthen its ability to deliver innovative, high-quality solutions to pharmaceutical and biotech partners worldwide.
Leadership Commentary
Simon Haydar, CSO of PI Health Sciences, commented:
“Our collaboration with Cresset to implement Torx® Software represents a pivotal advancement in our digital transformation journey. By leveraging cutting-edge technology and our scientific expertise, we are poised to accelerate drug discovery, enhance value delivery for our customers, and reinforce our position as a partner of choice for global innovators. This initiative aligns with our vision of leading with science, technology, and human ingenuity to create transformative solutions in life sciences.”
Tim C, CEO of Cresset commented:
“We are delighted to partner with PI Health Sciences in implementing our Torx® Software platform to drive their digital transformation in drug discovery. PI Health Sciences’ commitment to scientific excellence and innovation perfectly aligns with our mission to empower researchers with intuitive, collaborative tools that accelerate the design-make-test-analyze cycle. Together, we aim to enhance productivity, foster seamless collaboration, and ultimately deliver impactful solutions to advance global healthcare.”
About PI Health Sciences
PI Health Sciences, a subsidiary of PI Industries, is a leading Contract Research, Development, and Manufacturing Organization (CRDMO) with R&D and manufacturing locations in India and Europe. The company delivers fully integrated solutions from discovery through development and manufacturing, serving 25+ global innovators and prioritizing quality, IP protection, and industry leadership.
About Cresset and Torx® Software
Cresset is a pioneer in digital molecule design and cross-team communication, combining advanced science with AI/ML to accelerate drug discovery projects. Torx® Software, created in partnership with Elixir Software, is the only end to end DMTA solution for managing the entire molecule life-cycle, from ideation to synthesis, testing, and data analysis, in a single platform.
Media Contacts:
- PI Health Sciences: info@pihealthsciences.com
- Torx Software: enquiries@torx-software.com
This collaboration demonstrates PI Health Sciences’ ongoing commitment to leveraging technology and scientific excellence to reimagine a healthier planet and deliver differentiated value to stakeholders worldwide.